Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients

Vijayalaxmi, Michael Selva, Russel J Reiter, Martin L. Meltz, Thomas J. Prihoda, Jonathan Barnes, Belinda Z. Leal, Rajiv S. Dahiya, Terence S. Herman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

OBJECTIVES: The synthesis of melatonin, an endogenous compound synthesized by the pineal gland in the brain, is reported to be depressed in patients with primary cancers of the breast, prostate, stomach and rectum. It is not known whether patients with brain cancer exhibit altered melatonin synthesis. Also unknown is whether radiotherapy given to the region of the brain where the pineal gland is located affects the synthesis of melatonin. This information could be relevant to the clinician for the successful treatment of brain cancer patients since melatonin has been reported to be a potent oncostatic agent. METHODS: Urinary levels of 6-sulphatoxymelatonin, the chief metabolite of melatonin, are routinely used as an index of pineal melatonin production and secretion. In this study, the concentrations of 6-sulphatoxymelatonin (aMT6S) excreted in the urine before and during radiotherapy of patients with primary or metastatic brain cancer were determined and compared with the values obtained in breast or lung cancer patients who also received radiotherapy (excluding exposure of the brain where the pineal gland is located). RESULTS: The results showed a wide variation in the mean concentration of aMT6S excreted in the urine. CONCLUSION: The data from this preliminary study suggested that radiotherapy given to the region of human brain, where the pineal gland is located, does not significantly affect the excretion of aMT6S, the chief metabolite of melatonin.

Original languageEnglish (US)
Pages (from-to)203-207
Number of pages5
JournalNeuroendocrinology Letters
Volume21
Issue number3
StatePublished - 2000

Fingerprint

Melatonin
Brain Neoplasms
Radiotherapy
Urine
Pineal Gland
Brain
Breast Neoplasms
Rectal Neoplasms
6-sulfatoxymelatonin
Lung Neoplasms
Prostatic Neoplasms
Stomach

Keywords

  • 6-Sulphatoxymelatonin
  • Brain cancer
  • Breast cancer
  • Lung cancer
  • Radiotherapy

ASJC Scopus subject areas

  • Endocrinology
  • Neuroscience(all)

Cite this

Vijayalaxmi, Selva, M., Reiter, R. J., Meltz, M. L., Prihoda, T. J., Barnes, J., ... Herman, T. S. (2000). Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients. Neuroendocrinology Letters, 21(3), 203-207.

Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients. / Vijayalaxmi; Selva, Michael; Reiter, Russel J; Meltz, Martin L.; Prihoda, Thomas J.; Barnes, Jonathan; Leal, Belinda Z.; Dahiya, Rajiv S.; Herman, Terence S.

In: Neuroendocrinology Letters, Vol. 21, No. 3, 2000, p. 203-207.

Research output: Contribution to journalArticle

Vijayalaxmi, Selva, M, Reiter, RJ, Meltz, ML, Prihoda, TJ, Barnes, J, Leal, BZ, Dahiya, RS & Herman, TS 2000, 'Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients', Neuroendocrinology Letters, vol. 21, no. 3, pp. 203-207.
Vijayalaxmi ; Selva, Michael ; Reiter, Russel J ; Meltz, Martin L. ; Prihoda, Thomas J. ; Barnes, Jonathan ; Leal, Belinda Z. ; Dahiya, Rajiv S. ; Herman, Terence S. / Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients. In: Neuroendocrinology Letters. 2000 ; Vol. 21, No. 3. pp. 203-207.
@article{5de0eb62d845436e9010c019218afc3d,
title = "Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients",
abstract = "OBJECTIVES: The synthesis of melatonin, an endogenous compound synthesized by the pineal gland in the brain, is reported to be depressed in patients with primary cancers of the breast, prostate, stomach and rectum. It is not known whether patients with brain cancer exhibit altered melatonin synthesis. Also unknown is whether radiotherapy given to the region of the brain where the pineal gland is located affects the synthesis of melatonin. This information could be relevant to the clinician for the successful treatment of brain cancer patients since melatonin has been reported to be a potent oncostatic agent. METHODS: Urinary levels of 6-sulphatoxymelatonin, the chief metabolite of melatonin, are routinely used as an index of pineal melatonin production and secretion. In this study, the concentrations of 6-sulphatoxymelatonin (aMT6S) excreted in the urine before and during radiotherapy of patients with primary or metastatic brain cancer were determined and compared with the values obtained in breast or lung cancer patients who also received radiotherapy (excluding exposure of the brain where the pineal gland is located). RESULTS: The results showed a wide variation in the mean concentration of aMT6S excreted in the urine. CONCLUSION: The data from this preliminary study suggested that radiotherapy given to the region of human brain, where the pineal gland is located, does not significantly affect the excretion of aMT6S, the chief metabolite of melatonin.",
keywords = "6-Sulphatoxymelatonin, Brain cancer, Breast cancer, Lung cancer, Radiotherapy",
author = "Vijayalaxmi and Michael Selva and Reiter, {Russel J} and Meltz, {Martin L.} and Prihoda, {Thomas J.} and Jonathan Barnes and Leal, {Belinda Z.} and Dahiya, {Rajiv S.} and Herman, {Terence S.}",
year = "2000",
language = "English (US)",
volume = "21",
pages = "203--207",
journal = "Neuroendocrinology Letters",
issn = "0172-780X",
publisher = "Maghira and Maas Publications",
number = "3",

}

TY - JOUR

T1 - Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients

AU - Vijayalaxmi,

AU - Selva, Michael

AU - Reiter, Russel J

AU - Meltz, Martin L.

AU - Prihoda, Thomas J.

AU - Barnes, Jonathan

AU - Leal, Belinda Z.

AU - Dahiya, Rajiv S.

AU - Herman, Terence S.

PY - 2000

Y1 - 2000

N2 - OBJECTIVES: The synthesis of melatonin, an endogenous compound synthesized by the pineal gland in the brain, is reported to be depressed in patients with primary cancers of the breast, prostate, stomach and rectum. It is not known whether patients with brain cancer exhibit altered melatonin synthesis. Also unknown is whether radiotherapy given to the region of the brain where the pineal gland is located affects the synthesis of melatonin. This information could be relevant to the clinician for the successful treatment of brain cancer patients since melatonin has been reported to be a potent oncostatic agent. METHODS: Urinary levels of 6-sulphatoxymelatonin, the chief metabolite of melatonin, are routinely used as an index of pineal melatonin production and secretion. In this study, the concentrations of 6-sulphatoxymelatonin (aMT6S) excreted in the urine before and during radiotherapy of patients with primary or metastatic brain cancer were determined and compared with the values obtained in breast or lung cancer patients who also received radiotherapy (excluding exposure of the brain where the pineal gland is located). RESULTS: The results showed a wide variation in the mean concentration of aMT6S excreted in the urine. CONCLUSION: The data from this preliminary study suggested that radiotherapy given to the region of human brain, where the pineal gland is located, does not significantly affect the excretion of aMT6S, the chief metabolite of melatonin.

AB - OBJECTIVES: The synthesis of melatonin, an endogenous compound synthesized by the pineal gland in the brain, is reported to be depressed in patients with primary cancers of the breast, prostate, stomach and rectum. It is not known whether patients with brain cancer exhibit altered melatonin synthesis. Also unknown is whether radiotherapy given to the region of the brain where the pineal gland is located affects the synthesis of melatonin. This information could be relevant to the clinician for the successful treatment of brain cancer patients since melatonin has been reported to be a potent oncostatic agent. METHODS: Urinary levels of 6-sulphatoxymelatonin, the chief metabolite of melatonin, are routinely used as an index of pineal melatonin production and secretion. In this study, the concentrations of 6-sulphatoxymelatonin (aMT6S) excreted in the urine before and during radiotherapy of patients with primary or metastatic brain cancer were determined and compared with the values obtained in breast or lung cancer patients who also received radiotherapy (excluding exposure of the brain where the pineal gland is located). RESULTS: The results showed a wide variation in the mean concentration of aMT6S excreted in the urine. CONCLUSION: The data from this preliminary study suggested that radiotherapy given to the region of human brain, where the pineal gland is located, does not significantly affect the excretion of aMT6S, the chief metabolite of melatonin.

KW - 6-Sulphatoxymelatonin

KW - Brain cancer

KW - Breast cancer

KW - Lung cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0034119786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034119786&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 203

EP - 207

JO - Neuroendocrinology Letters

JF - Neuroendocrinology Letters

SN - 0172-780X

IS - 3

ER -